Advertisement

Topics

Antibiotics Reduced Efficacy of Checkpoint Inhibitors in RCC, NSCLC

14:49 EDT 16 Apr 2018 | Cancer Networks

Antibiotics administered within 30 days of starting immunotherapy reduced both PFS and OS for patients with advanced RCC and NSCLC.

Original Article: Antibiotics Reduced Efficacy of Checkpoint Inhibitors in RCC, NSCLC

NEXT ARTICLE

More From BioPortfolio on "Antibiotics Reduced Efficacy of Checkpoint Inhibitors in RCC, NSCLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...